These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Johnson DC; Hegde NR Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504 [TBL] [Abstract][Full Text] [Related]
4. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus. Powers CJ; Früh K PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297 [TBL] [Abstract][Full Text] [Related]
5. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106 [TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus US3 modulates destruction of MHC class I molecules. Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807 [TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826 [TBL] [Abstract][Full Text] [Related]
8. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection. Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887 [TBL] [Abstract][Full Text] [Related]
9. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Benz C; Hengel H Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788 [TBL] [Abstract][Full Text] [Related]
10. Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus. Greijer AE; Adriaanse HM; Kahl M; Tacken NM; Oldenburg N; Sijlmans A; van de Crommert JM; Dekkers CA; Sillekens PT; Middeldorp JM J Virol Methods; 2001 Aug; 96(2):133-47. PubMed ID: 11445144 [TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. Huber MT; Tomazin R; Wisner T; Boname J; Johnson DC J Virol; 2002 Jun; 76(11):5748-58. PubMed ID: 11992003 [TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296 [TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135 [TBL] [Abstract][Full Text] [Related]
14. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839 [TBL] [Abstract][Full Text] [Related]
15. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. Chevalier MS; Daniels GM; Johnson DC J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032 [TBL] [Abstract][Full Text] [Related]
16. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4 Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T Front Immunol; 2018; 9():1129. PubMed ID: 29887865 [TBL] [Abstract][Full Text] [Related]
17. Effect of the R1 element on expression of the US3 and US6 immune evasion genes of human cytomegalovirus. Bullock GC; Lashmit PE; Stinski MF Virology; 2001 Sep; 288(1):164-74. PubMed ID: 11543669 [TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. Chevalier MS; Johnson DC J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells engineered to inhibit complement-mediated damage. Soland MA; Bego M; Colletti E; Zanjani ED; St Jeor S; Porada CD; Almeida-Porada G PLoS One; 2013; 8(3):e60461. PubMed ID: 23555976 [TBL] [Abstract][Full Text] [Related]
20. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]